Neurologic clinical trial - ACT16970

Status:

Open/Enrolling

ClinicalTrials.gov:

NCT05237284

ACT16970

Drug

SAR443820

Phase

Phase II

Condition

Amyotrophic Lateral Sclerosis

Keywords

ALS | Amyotrophic Lateral Sclerosis